diarrhea: be common side-effect of chemotherapy

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents infection
Weight: 0.74
, illness
Weight: 0.73
, complication
Weight: 0.66
, complaint
Weight: 0.63
, reaction
Weight: 0.61
Siblings gastroenteritis
Weight: 0.39
, typhoid fever
Weight: 0.39
, lyme disease
Weight: 0.39
, pneumonia
Weight: 0.38
, malaria
Weight: 0.37

Related properties

Property Similarity
be common side-effect of chemotherapy 1.00
be common after surgery 0.77
be constant risk to patient on immunosuppressive agents 0.76
treatment 0.75
occur at tumor site 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.46
Rule weight: 0.66
Evidence weight: 0.91
Similarity weight: 0.76
Evidence: 0.89
Plausible(infection, be constant risk to patient on immunosuppressive agents)
Evidence: 0.90
¬ Typical(diarrhea, be common side-effect of chemotherapy)
0.31
Rule weight: 0.66
Evidence weight: 0.62
Similarity weight: 0.75
Evidence: 0.57
Plausible(infection, occur at tumor site)
Evidence: 0.90
¬ Typical(diarrhea, be common side-effect of chemotherapy)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.88
Similarity weight: 0.75
Evidence: 0.80
Plausible(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.57
¬ Plausible(infection, occur at tumor site)
0.06
Rule weight: 0.09
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.80
Plausible(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.89
¬ Plausible(infection, be constant risk to patient on immunosuppressive agents)

Remarkability exclusitivity betweem a parent and a child

0.32
Rule weight: 0.58
Evidence weight: 0.72
Similarity weight: 0.76
Evidence: 0.44
¬ Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.62
¬ Remarkable(infection, be constant risk to patient on immunosuppressive agents)
0.26
Rule weight: 0.58
Evidence weight: 0.61
Similarity weight: 0.75
Evidence: 0.44
¬ Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.88
¬ Remarkable(infection, occur at tumor site)

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.83
Similarity weight: 0.77
Evidence: 0.44
¬ Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.37
¬ Remarkable(pneumonia, be common after surgery)
0.06
Rule weight: 0.13
Evidence weight: 0.58
Similarity weight: 0.75
Evidence: 0.44
¬ Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.94
¬ Remarkable(gastroenteritis, treatment)

Remarkability from parent implausibility

0.31
Rule weight: 0.42
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.89
Plausible(infection, be constant risk to patient on immunosuppressive agents)
Evidence: 0.44
Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.80
¬ Plausible(diarrhea, be common side-effect of chemotherapy)
0.26
Rule weight: 0.42
Evidence weight: 0.81
Similarity weight: 0.75
Evidence: 0.57
Plausible(infection, occur at tumor site)
Evidence: 0.44
Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.80
¬ Plausible(diarrhea, be common side-effect of chemotherapy)

Remarkability from sibling implausibility

0.45
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.75
Evidence: 0.80
Plausible(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.94
Remarkable(gastroenteritis, treatment)
Evidence: 0.36
¬ Plausible(gastroenteritis, treatment)
0.42
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.77
Evidence: 0.80
Plausible(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.37
Remarkable(pneumonia, be common after surgery)
Evidence: 0.74
¬ Plausible(pneumonia, be common after surgery)

Salient implies Plausible

0.24
Rule weight: 0.28
Evidence weight: 0.84
Similarity weight: 1.00
Evidence: 0.80
Plausible(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.78
¬ Salient(diarrhea, be common side-effect of chemotherapy)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.78
Salient(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.90
¬ Typical(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.44
¬ Remarkable(diarrhea, be common side-effect of chemotherapy)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.80
Plausible(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.90
¬ Typical(diarrhea, be common side-effect of chemotherapy)

Typicality and Rermarkability incompatibility between a parent and a child

0.31
Rule weight: 0.51
Evidence weight: 0.80
Similarity weight: 0.75
Evidence: 0.44
¬ Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.45
¬ Typical(infection, occur at tumor site)
0.23
Rule weight: 0.51
Evidence weight: 0.58
Similarity weight: 0.76
Evidence: 0.44
¬ Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.94
¬ Typical(infection, be constant risk to patient on immunosuppressive agents)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 0.75
Evidence: 0.44
¬ Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.14
¬ Typical(gastroenteritis, treatment)
0.06
Rule weight: 0.14
Evidence weight: 0.61
Similarity weight: 0.77
Evidence: 0.44
¬ Remarkable(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.87
¬ Typical(pneumonia, be common after surgery)

Typicality inheritance from parent to child

0.35
Rule weight: 0.48
Evidence weight: 0.95
Similarity weight: 0.75
Evidence: 0.90
Typical(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.45
¬ Typical(infection, occur at tumor site)
0.33
Rule weight: 0.48
Evidence weight: 0.90
Similarity weight: 0.76
Evidence: 0.90
Typical(diarrhea, be common side-effect of chemotherapy)
Evidence: 0.94
¬ Typical(infection, be constant risk to patient on immunosuppressive agents)